Here is a comprehensive overview of hyperventilation management:
Hyperventilation Management
Definition & Pathophysiology
Hyperventilation is breathing in excess of metabolic needs, resulting in a fall in PaCO₂ (hypocapnia) and respiratory alkalosis. This causes cerebral vasoconstriction and peripheral neuromuscular irritability, producing the characteristic symptoms.
Causes
Acute hyperventilation must be distinguished from chronic, as many serious systemic conditions can present with hyperventilation:
| Category | Examples |
|---|
| Metabolic | Diabetic ketoacidosis, salicylate poisoning, lactic acidosis |
| Cardiopulmonary | Pulmonary embolism, hypoxia, pneumonia, heart failure |
| CNS | Stroke, meningitis, raised ICP |
| Psychological | Panic disorder, anxiety, somatization |
| Physiologic | Pain, fever, pregnancy |
| Iatrogenic | Mechanical over-ventilation |
Diagnosis
Per Harrison's Principles of Internal Medicine (p. 8113):
- Exclude serious underlying causes first — acute hyperventilation can be the initial manifestation of DKA, PE, or other systemic illness
- Arterial blood gas (ABG):
- Low PaCO₂ (< 35 mmHg)
- Low calculated bicarbonate (compensatory)
- Near-normal pH in chronic cases (compensated respiratory alkalosis)
- Rule out other causes of respiratory alkalosis (e.g., mild asthma)
- Chronic hyperventilation syndrome is a diagnosis of exclusion
Classic symptoms of hypocapnia:
- Perioral and peripheral paresthesias (tingling)
- Lightheadedness, dizziness, presyncope
- Chest tightness, palpitations
- Carpopedal spasm (Trousseau's sign)
- Tetany (severe cases)
Management
Acute Episode
| Step | Action |
|---|
| 1. Treat the underlying cause | Always the priority — rule out PE, DKA, sepsis, etc. |
| 2. Reassurance & calm environment | Reduces anxiety-driven hyperventilation |
| 3. Controlled breathing coaching | Slow, diaphragmatic breathing; target RR ~12/min |
| 4. Rebreathing (paper bag) | Historically used; no longer routinely recommended — risk of hypoxia if organic cause is missed |
| 5. Sedation/anxiolytics | Benzodiazepines (e.g., lorazepam) for refractory panic-driven episodes |
Caution: Never use the paper bag technique without first excluding hypoxia and organic causes.
Chronic Hyperventilation Syndrome
Per Harrison's (p. 8114), there are few well-controlled treatment studies, but accepted approaches include:
-
Patient education & reassurance
- Explain the mechanism; this can be "liberating" for many patients
- Frank discussion of the role of anxiety and habit
-
Identify and eliminate perpetuating habits
- Frequent yawning, sighing, mouth breathing
-
Breathing retraining
- Diaphragmatic (abdominal) breathing exercises
- Pursed-lip breathing
- Capnography biofeedback (in specialist centers)
-
Physiotherapy
- Structured respiratory physiotherapy programs have moderate evidence
-
Pharmacotherapy
- Evidence is limited
- Beta-blockers (e.g., propranolol): helpful for sympathetically mediated symptoms such as palpitations and tremors (Harrison's, p. 8114)
- SSRIs/SNRIs: if underlying panic disorder or anxiety is the driver
- Benzodiazepines: short-term only; avoid long-term dependence
-
Psychological treatment
- Cognitive behavioral therapy (CBT) — most effective for panic disorder-related hyperventilation
- Mindfulness and relaxation therapy
Special Considerations
- Mechanically ventilated patients: Adjust ventilator settings (lower RR or tidal volume) to correct iatrogenic hyperventilation; target PaCO₂ 35–45 mmHg (except in raised ICP management where permissive hypocapnia may be intentional)
- Raised ICP: Controlled hyperventilation (PaCO₂ 30–35 mmHg) is used as a temporizing measure to reduce cerebral blood flow, but not as definitive therapy
- Pregnancy: Mild hypocapnia (PaCO₂ ~30 mmHg) is physiologically normal — do not over-treat
Key Takeaway
The cornerstone of hyperventilation management is identifying and treating the underlying cause. In functional/chronic hyperventilation syndrome, breathing retraining and patient education are first-line; medications play a limited, adjunctive role (Harrison's, p. 8114).